Seah Lim

Chief Executive Officer at Medicovestor.

Raised on Medicovestor filings

$3.2M

of $4.1M offered across 1 Form D filing

Company

Biotech · New York, NY

Dimeric antibody-drug conjugates for low-antigen tumors

Dimeric antibody-drug conjugates for low-antigen tumors

Medicovestor Form D filings
Filed	Security	Sold of offered	Filing
Dec 5, 2025	Equity	$3.2M/ $4.1M	Form D

Also named on Medicovestor filings